AKTS
Aktis Oncology, Inc.Company with tickers: AKTS
CIK
2035832
CUSIP
01021M104
Shares Outstanding
53,296,950
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-01-12 | Foley Todd | Director, 10% Owner | Other | 597,391 |
| 2026-01-12 | Foley Todd | Director, 10% Owner | Other | 2,727,273 |
| 2026-01-12 | Foley Todd | Director, 10% Owner | Other | 10,227,273 |
| 2026-01-12 | Foley Todd | Director, 10% Owner | Other | 2,272,727 |
| 2026-01-12 | Foley Todd | Director, 10% Owner | Buy | 232,870 |
| 2026-01-12 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Other | 22,500,000 |
| 2026-01-12 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Other | 5,000,000 |
| 2026-01-12 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Other | 1,314,262 |
| 2026-01-12 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Buy | 1,112,777 |
| 2026-01-12 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Other | 6,000,000 |
| 2026-01-12 | GADICKE ANSBERT | Director | Other | 5,000,000 |
| 2026-01-12 | GADICKE ANSBERT | Director | Buy | 1,112,777 |
| 2026-01-12 | GADICKE ANSBERT | Director | Other | 1,314,262 |
| 2026-01-12 | GADICKE ANSBERT | Director | Other | 22,500,000 |
| 2026-01-12 | GADICKE ANSBERT | Director | Other | 6,000,000 |
| 2026-01-12 | EcoR1 Capital, LLC | Director, 10% Owner | Other | 9,913,810 |
| 2026-01-12 | EcoR1 Capital, LLC | Director, 10% Owner | Other | 965,190 |
| 2026-01-12 | EcoR1 Capital, LLC | Director, 10% Owner | Other | 2,270,879 |
| 2026-01-12 | EcoR1 Capital, LLC | Director, 10% Owner | Other | 2,397,500 |
| 2026-01-12 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 2,077,779 |
| 2026-01-12 | Vida Ventures II, LLC | 10% Owner | Other | 14,838,250 |
| 2026-01-12 | Vida Ventures II, LLC | 10% Owner | Other | 4,859,370 |
| 2026-01-12 | Vida Ventures II, LLC | 10% Owner | Other | 3,648,750 |
| 2026-01-12 | Vida Ventures II, LLC | 10% Owner | Buy | 812,455 |
| 2026-01-12 | Kim Helen Susan | Director, 10% Owner | Other | 3,648,750 |
| 2026-01-12 | Kim Helen Susan | Director, 10% Owner | Other | 4,859,370 |
| 2026-01-12 | Kim Helen Susan | Director, 10% Owner | Other | 14,838,250 |
| 2026-01-12 | Kim Helen Susan | Director, 10% Owner | Buy | 812,455 |
| 2026-01-12 | Segal Lloyd Mitchell | Director | Other | 24,687 |
| 2026-01-12 | Segal Lloyd Mitchell | Director | Other | 50,000 |
| 2026-01-12 | Segal Lloyd Mitchell | Director | Other | 19,631 |
| 2026-01-08 | Kuvalanka Kyle D. | Chief Financial Officer | Other | 0 |
| 2026-01-08 | Kim Helen Susan | Director, 10% Owner | Other | 0 |
| 2026-01-08 | Kim Helen Susan | Director, 10% Owner | Other | 0 |
| 2026-01-08 | Kim Helen Susan | Director, 10% Owner | Other | 0 |
| 2026-01-08 | Herrmann Ken | Director | Other | 0 |
| 2026-01-08 | GADICKE ANSBERT | Director | Other | 0 |
| 2026-01-08 | GADICKE ANSBERT | Director | Other | 0 |
| 2026-01-08 | GADICKE ANSBERT | Director | Other | 341,709 |
| 2026-01-08 | GADICKE ANSBERT | Director | Other | 0 |
| 2026-01-08 | Segal Lloyd Mitchell | Director | Other | 0 |
| 2026-01-08 | Segal Lloyd Mitchell | Director | Other | 0 |
| 2026-01-08 | Segal Lloyd Mitchell | Director | Other | 0 |
| 2026-01-08 | RODEN MATTHEW | Director, President and CEO | Other | 0 |
| 2026-01-08 | RODEN MATTHEW | Director, President and CEO | Other | 91,998 |
| 2026-01-08 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Other | 0 |
| 2026-01-08 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Other | 341,709 |
| 2026-01-08 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Other | 0 |
| 2026-01-08 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Other | 0 |
| 2026-01-08 | Foley Todd | Director, 10% Owner | Other | 0 |
| 2026-01-08 | Foley Todd | Director, 10% Owner | Other | 0 |
| 2026-01-08 | Foley Todd | Director, 10% Owner | Other | 0 |
| 2026-01-08 | Foley Todd | Director, 10% Owner | Other | 0 |
| 2026-01-08 | EcoR1 Capital, LLC | Director, 10% Owner | Other | 0 |
| 2026-01-08 | EcoR1 Capital, LLC | Director, 10% Owner | Other | 0 |
| 2026-01-08 | EcoR1 Capital, LLC | Director, 10% Owner | Other | 0 |
| 2026-01-08 | Vida Ventures II, LLC | 10% Owner | Other | 0 |
| 2026-01-08 | Vida Ventures II, LLC | 10% Owner | Other | 0 |
| 2026-01-08 | Ron-Bigger Shulamit | Chief Operating Officer | Other | 0 |
| 2026-01-08 | Feldman Paul L | Chief Scientific Officer | Other | 0 |
| 2026-01-08 | Feldman Paul L | Chief Scientific Officer | Other | 144,568 |
| 2026-01-08 | Czibere Akos | Chief Medical Officer | Other | 0 |
| 2026-01-08 | Sherman Michael A. | Director | Other | 0 |
| 2026-01-08 | Thistle Mary | Director | Other | 0 |